Atrial Fibrillation in Long Term Care

Gurwitz, 1997, Atrial fibrillation and stroke prevention with warfarin in the long-term care setting, Arch Intern Med, 157, 978, 10.1001/archinte.1997.00440300080006 Latif, 2005, Predictors of anticoagulation prescription in nursing home residents with atrial fibrillation, J Am Med Dir Assoc, 6, 128, 10.1016/j.jamda.2005.01.006 McCormick, 2001, Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting, Arch Intern Med, 161, 2458, 10.1001/archinte.161.20.2458 Reardon, 2012, Prevalence of atrial fibrillation in U.S. nursing homes: Results from the National Nursing Home Survey, 1985–2004, JAMDA, 13, 529 Gage, 2001, Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation, JAMA, 285, 2864, 10.1001/jama.285.22.2864 Lip, 2010, Improving stroke risk stratification in atrial fibrillation, Am J Med, 123, 484, 10.1016/j.amjmed.2009.12.013 Wolf, 1991, Atrial fibrillation as an independent risk factor for stroke: The Framingham Study, Stroke, 22, 983, 10.1161/01.STR.22.8.983 Avgil-Tsadok, 2012, Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation, JAMA, 307, 1952, 10.1001/jama.2012.3490 Fuster, 2011, 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation, J Am Coll Cardiol, 57, e101, 10.1016/j.jacc.2010.09.013 De Denus, 2005, Rate vs. rhythm control in patients with atrial fibrillation: A meta-analysis, Arch Intern Med, 165, 258, 10.1001/archinte.165.3.258 Caldeira, 2011, Rate vs rhythm control in patients with atrial fibrillation and heart failure: A systematic review and meta-analysis of randomised controlled trials, Eur J Intern Med, 22, 448, 10.1016/j.ejim.2011.05.001 Lane, 2009, Quality of life in older people with atrial fibrillation, J Intervent Cardiac Electrophys, 25, 37, 10.1007/s10840-008-9318-y Van Gelder, 2010, Lenient versus strict rate control in patients with atrial fibrillation, N Engl J Med, 362, 1363, 10.1056/NEJMoa1001337 Saksena, 2011, Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses, J Am Coll Cardiol, 58, 1975, 10.1016/j.jacc.2011.07.036 Hohnloser, 2009, Effect of dronedarone on cardiovascular events in atrial fibrillation, N Engl J Med, 360, 668, 10.1056/NEJMoa0803778 Connolly, 2011, Dronedarone in high-risk permanent atrial fibrillation, N Engl J Med, 365, 2268, 10.1056/NEJMoa1109867 Crandall, 2009, Contemporary management of atrial fibrillation: Update on anticoagulation and invasive management strategies, Mayo Clin Proc, 84, 643, 10.1016/S0025-6196(11)60754-4 Wazni, 2011, Catheter ablation for atrial fibrillation, N Engl J Med, 365, 2296, 10.1056/NEJMct1109977 Lee, 2009, The surgical treatment of atrial fibrillation, Surg Clin North Am, 89, 1001, 10.1016/j.suc.2009.06.001 Yamada, 2009, Catheter ablation of atrial fibrillation in the elderly, Pacing Clin Electrophys, 32, 1085, 10.1111/j.1540-8159.2009.02442.x Mant, 2007, Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A randomised controlled trial, Lancet, 370, 493, 10.1016/S0140-6736(07)61233-1 White, 2007, Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: Results from SPORTIF III and V, Arch Intern Med, 167, 239, 10.1001/archinte.167.3.239 Connolly, 2008, Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range, Circulation, 118, 2029, 10.1161/CIRCULATIONAHA.107.750000 Hankey, 2011, Dabigatran etexilate: A new oral thrombin inhibitor, Circulation, 123, 1436, 10.1161/CIRCULATIONAHA.110.004424 Connolly, 2009, Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med, 361, 1139, 10.1056/NEJMoa0905561 Harper, 2012, Bleeding risk with dabigatran in the frail elderly, N Engl J Med, 366, 864, 10.1056/NEJMc1112874 Patel, 2011, Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N Engl J Med, 365, 883, 10.1056/NEJMoa1009638 Granger, 2011, Apixaban versus warfarin in patients with atrial fibrillation, N Engl J Med, 365, 981, 10.1056/NEJMoa1107039 Monette, 1997, Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: Results of a survey of long-term care practitioners, J Am Geriatr Soc, 45, 1060, 10.1111/j.1532-5415.1997.tb05967.x Garwood, 2008, Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls, Ann Pharmacother, 42, 523, 10.1345/aph.1K498 Lau, 2004, Stroke prophylaxis in institutionalized elderly patients with atrial fibrillation, J Am Geriatr Soc, 52, 428, 10.1111/j.1532-5415.2004.52117.x Singh, 2011, Evaluation of antithrombotic usage for atrial fibrillation in aged care facilities, J Clin Pharm Ther, 36, 166, 10.1111/j.1365-2710.2010.01167.x Connolly, 2009, Effect of clopidogrel added to aspirin in patients with atrial fibrillation, N Engl J Med, 360, 2066, 10.1056/NEJMoa0901301 Budnitz, 2011, Emergency hospitalizations for adverse drug events in older Americans, N Engl J Med, 365, 2002, 10.1056/NEJMsa1103053 Gurwitz, 2007, The safety of warfarin therapy in the nursing home setting, Am J Med, 120, 539, 10.1016/j.amjmed.2006.07.045